Rhumbline Advisers Neuronetics, Inc. Transaction History

Rhumbline Advisers

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 11, 2022	SELL	$2.09 - $3.71 $40,228 - $71,410	-19,248 Closed	0 $0
Q1 2022 May 12, 2022	BUY	$2.84 - $4.52 $1,587 - $2,526	559 Added 2.99%	19,248 $58,000
Q4 2021 Feb 10, 2022	SELL	$3.87 - $6.59 $2,294 - $3,907	-593 Reduced 3.08%	18,689 $83,000
Q3 2021 Nov 12, 2021	BUY	$6.22 - $15.54 $9,199 - $22,983	1,479 Added 8.31%	19,282 $126,000
Q2 2021 Aug 05, 2021	BUY	$10.15 - $17.25 $180,700 - $307,101	17,803 New	17,803 $285,000

Q2 2020 Aug 13, 2020	SELL	$1.41 - $2.61 $22,785 - $42,177	-16,160 Closed	0 $0
Q4 2019 Feb 05, 2020	BUY	$4.03 - $9.22 $294 - $673	73 Added 0.45%	16,160 $73,000
Q3 2019 Oct 23, 2019	SELL	$8.31 - $13.03 $1,038 - $1,628	-125 Reduced 0.77%	16,087 $134,000
Q2 2019 Aug 14, 2019	BUY	$9.0 - $17.2 $25,299 - $48,349	2,811 Added 20.98%	16,212 $203,000
Q1 2019 May 01, 2019	BUY	$13.6 - $19.58 $182,253 - $262,391	13,401 New	13,401 $204,000

18.4M

200

3.6K

Ticker STIM
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 27,022,800
Market Cap $47.3M
Description
Neuronetics, Inc., a commercial stage medical technology company, designs, develops, and markets products for patients with neurohealth disorders in the United States and internationally. The company offers NeuroStar Advanced Therapy System, a non-invasive and non-systemic office-based treatment to treat adult patients with major depressive diso...

Get notified when there are updates to the investment portfolio of Rhumbline Advisers, based on Form 13F filings with the SEC.

Stay updated on Rhumbline Advisers with notifications on news.